title: Use of a functional classification of anemia in myelodysplastic syndromes to identify subgroups of patients responsive to recombinant human-erythropoietin therapy.
authors.forename: A
authors.initials: A
authors.lastname: Bucalossi
authors.forename: G
authors.initials: G
authors.lastname: Marotta
authors.forename: C
authors.initials: C
authors.lastname: Bigazzi
authors.forename: P
authors.initials: P
authors.lastname: Galieni
authors.forename: F
authors.initials: F
authors.lastname: Vessihelli
authors.forename: R
authors.initials: R
authors.lastname: Falbo
authors.forename: E
authors.initials: E
authors.lastname: Dispensa
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000145:classification* / Q000188:drug therapy* / Q000235:genetics; D015415:Biomarkers; D004921:Erythropoietin / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007621:Karyotyping; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000145:classification* / Q000188:drug therapy* / Q000235:genetics; D011990:Receptors, Transferrin / Q000032:analysis; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D015415:Biomarkers; D011990:Receptors, Transferrin; D011994:Recombinant Proteins; D004921:Erythropoietin